AbbVie Biotechnology Ltd

13D and 13G Filings

13D/G filings
13G on 1 security
CIK
0002014668
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13G · 1 security · passive
Carisma Therapeutics Inc. 13G/A
CARM · 14216R101
4.4% 4/25/2025
Event 3/31/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.